Hematologic abnormalities occur in both cortical and lacunar infarction.
- 1 December 1993
- journal article
- abstracts
- Published by Wolters Kluwer Health in Stroke
- Vol. 24 (12) , 1945-1950
- https://doi.org/10.1161/01.str.24.12.1945
Abstract
Primary hematologic abnormalities are a rare but established cause of ischemic stroke. In addition, activation of hemostatic parameters is often present during the acute phase of stroke. However, it is uncertain whether these abnormalities occur in both cortical and lacunar infarction; this study aimed to further assess this issue. Hematologic parameters (prothrombin, activated partial thromboplastin, thrombin clotting, and euglobulin lysis times; and fibrinogen, fibrinopeptide A, antithrombin III, protein C, protein S, and plasminogen levels) were measured in 19 patients within 48 hours of the onset of acute cerebral infarction. These patients included 10 with cortical infarcts and 9 with lacunar infarcts, as determined by standard clinical and radiological criteria. Five patients with lacunar infarction and 7 patients with cortical infarction demonstrated raised fibrinopeptide A levels, indicating enhanced thrombin activity. Fibrinolysis, assessed by the euglobulin lysis time, was impaired in 6 of 9 patients with lacunar infarction and in 2 of 10 patients with cortical infarction. Lupus anticoagulants were detected in 3 patients with lacunar infarction and in 1 patient with cortical infarction. Three patients in each group displayed decreased antithrombin III function, and 1 patient with a lacunar infarction had a low protein C level. Primary hematologic disorders and secondary hemostatic derangements may occur in patients with either cortical or lacunar infarction.Keywords
This publication has 17 references indexed in Scilit:
- Acute stroke outcome: effects of stroke type and risk factorsAustralian and New Zealand Journal of Medicine, 1992
- Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. The Antiphospholipid Antibodies in Stroke Study Group.Stroke, 1990
- Hypercoagulability in acute ischemic stroke: Analysis of the extrinsic coagulation reactions in plasma by a highly sensitive automated methodThrombosis Research, 1990
- Antiphospholipid antibodiesAnnals of Neurology, 1989
- Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and strokeThe American Journal of Cardiology, 1988
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Activation of coagulation and fibrinolytic systems following strokeBritish Journal of Haematology, 1983
- A solid phase immuno enzymological assay for the measurement of human fibrinopeptide AThrombosis Research, 1980
- PLATELET ACTIVATION IN ACUTE CEREBRAL ISCHÆMIAThe Lancet, 1977
- Blood coagulation and plasma fibrinolytic enzyme system pathophysiology in stroke.Stroke, 1976